# Chinese Medicine Treat for Hypertensive Renal Injury

> **NCT04078711** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Jiangsu Province Hospital of Traditional Chinese Medicine** · enrollment: 520 (estimated)

## Conditions studied

- Hypertension
- Renal Injury

## Interventions

- **DRUG:** Losartan 100Mg Tab
- **DRUG:** Qianyangyuyin 20g Granule
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04078711
- **Lead sponsor:** Jiangsu Province Hospital of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-10
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 520 (ESTIMATED)
- **Last updated:** 2019-09-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04078711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04078711, "Chinese Medicine Treat for Hypertensive Renal Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04078711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*